Overview
Pierre-michel Llorca practices in Clermont-ferrand, France. Llorca is rated as a Distinguished expert by MediFind in the treatment of Schizophrenia. Their top areas of expertise are Schizophrenia, Bipolar Disorder (BPD), Abdominal Obesity Metabolic Syndrome, Metabolic Syndrome, and Deep Brain Stimulation.
Their clinical research consists of co-authoring 301 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 129 articles in the study of Schizophrenia.
Locations
Clermont-ferrand, France
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
5 Clinical Trials
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Bipolar Disorder (BPD)Llorca isDistinguished. Learn about Bipolar Disorder (BPD).
- SchizophreniaLlorca isDistinguished. Learn about Schizophrenia.
- Advanced
- Abdominal Obesity Metabolic Syndrome
- AnorexiaLlorca isAdvanced. Learn about Anorexia.
- Metabolic SyndromeLlorca isAdvanced. Learn about Metabolic Syndrome.
- Experienced
- Attention Deficit Hyperactivity Disorder (ADHD)
- COVID-19Llorca isExperienced. Learn about COVID-19.
- Cyclothymic DisorderLlorca isExperienced. Learn about Cyclothymic Disorder.
- Deep Brain StimulationLlorca isExperienced. Learn about Deep Brain Stimulation.
- Developmental Dysphasia Familial
- Drug Induced DyskinesiaLlorca isExperienced. Learn about Drug Induced Dyskinesia.